ESPOIR - Assessment and Follow-Up of Early Undifferentiated Rheumatoid Arthritis

Head :
Combe Bernard

Last update : 07/22/2015 | Version : 2 | ID : 6711

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Assessment and Follow-Up of Early Undifferentiated Rheumatoid Arthritis
Sign or acronym ESPOIR
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL: 902156 (02-1387); Afssaps: DGS 2002/0541; n°CPP: 02 03 07 (12/07/2002)
General Aspects
Medical area Rheumatology
Health determinants Addictions
Genetic
Occupation
Social and psychosocial factors
Keywords rheumatoid arthritis, Cohort
Scientific investigator(s) (Contact)
Name of the director Combe
Surname Bernard
Address 371 avenue du Doyen Gaston Giraud 34090 Montpellier
Phone +33 (0)4 67 33 87 10
Email b-combe@chu-montpellier.fr
Organization Société Française de Rhumatologie
Collaborations
Funding
Funding status Mixed
Details Société Française de Rhumatologie - Institut National de la Santé et de la Recherche Médicale- Laboratoire MSD- Laboratoire Pfizer- Laboratoire Abbvie- Laboratoire Roche Chugai
Governance of the database
Sponsor(s) or organisation(s) responsible Société Française de Rhumatologie
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Cohort study
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Multi-centric from pre-inclusion criteria.
Database objective
Main objective To form a multicentric French cohort for early arthritis (less than 6 months duration) in order to establish a database for diagnostic, prognostic, medico-economic and pathogenetic studies.
Inclusion criteria - Men or women - between 18 and 70 years old - affiliated with a social security scheme - who have at least 2 forms of arthritis for less than 6 weeks/months - who have not received any corticosteroids within the last 6 months (except for treatments lasting less than 2 weeks and infiltration if over 4 weeks before inclusion; except for oral steroid therapy over a period less than 2 weeks, averaging less than 20mg/day, concluded at least 15 days prior to inclusion)
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Population covered Sick population
Gender Male
Woman
Geography area National
Detail of the geography area France CHU Nord (Amiens), CHU Pellegrin Tripode (Bordeaux), CHU La Cavale Blanche (Brest), CHU R.Salengro (Lille), CHU Lapeyronie (Montpellier), CHU St Antoine (Paris), CHU Avicenne (Paris), CHU La Pitié Salpétrière (Paris), CHU Cochin (Paris), CHU Bicêtre (Paris), CHU Bichat-Lariboisière (Paris), CHU Bois Guillaume (Rouen), CHU Hautepierre (Strasbourg), CHU Trousseau (Tours)
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 10/2002
Size of the database
Size of the database (number of individuals) [500-1000[ individuals
Details of the number of individuals 813
Data
Database activity Current data collection
Type of data collected Clinical data
Declarative data
Paraclinical data
Biological data
Administrative data
Clinical data (detail) Medical registration
Declarative data (detail) Paper self-questionnaire
Face to face interview
Phone interview
Paraclinical data (detail) - frontal hand and wrist x-rays, frontal and three quarter feet x-rays - feet and hand ultrasounds - hand and feet MRI (only in certain centres)
Biological data (detail) DNA (tissue and synovial fluid), serums, usual biological samples: blood count, platelets, erythrocyte sedimentation rate, C-reactive protein, aspartate aminotransferase, alanine aminotransferase, gamma GT (baseline), glucose, rheumatoid factor, anti-cyclic citrullinated peptide, antinuclear antibodies (baseline), anti-native DNA (baseline), human leukocyte antigens (baseline) alkaline phosphatase (baseline), creatine (baseline)
Administrative data (detail) Gender, date of birth, place of birth, ethnic origin, level of education
Presence of a biobank Yes
Contents of biobank Serum
Fluids (saliva, urine, amniotic fluid, …)
Tissues
DNA
Details of biobank content Serum bank, other fluids, tissue, DNA bank
Health parameters studied Health event/morbidity
Health care consumption and services
Quality of life/health perception
Care consumption (detail) Hospitalization
Medical/paramedical consultation
Medicines consumption
Procedures
Data collection method Data gathered by CRF and recorded on Access database. Data sent weekly to coordinating centre.
Participant monitoring Yes
Details on monitoring of participants Total follow-up duration: 10 years (current request for 10 additional years for a total duration of 20 years in progress). Follow-up every 6 months for 2 years and then becoming annual. Self-administered questionnaire, medical examination and normal biological samples are carried out at each visit. X-rays are carried out at baseline, 6 months, 12 months, 18 months, 2 years, 3 years, 5 years and 10 years. Biobank (serum) is carried out at baseline, 6 months, 12 months, 18 months, 2 years, 3 years, 5 years and 10 years. Urine is collected at baseline until 2 years. An overview of patients who were not followed-up (lost to follow-up, refusal) is carried out twice a year.
Links to administrative sources No
Promotion and access
Promotion
Link to the document http://sfr.larhumatologie.fr/rc/rhumatologie/htm/Article/2010/59d645a5cc26d0e80d4052f3ca0a70ab/src/htm_fullText/fr/Combe%20ESPOIR%20bonsoi_JBS%20271911.pdf
Link to the document http://sfr.larhumatologie.fr/rc/rhumatologie/htm/Article/2010/59d645a5cc26d0e80d4052f3ca0a70ab/src/htm_fullText/fr/Fautrel%20Rheumatology%202009%2009-0579.pdf
Link to the document http://sfr.larhumatologie.fr/rc/rhumatologie/htm/Article/2010/59d645a5cc26d0e80d4052f3ca0a70ab/src/htm_fullText/fr/090201-Echo%20ESPOIR.pdf
Link to the document http://sfr.larhumatologie.fr/rc/rhumatologie/htm/Article/2010/59d645a5cc26d0e80d4052f3ca0a70ab/src/htm_fullText/fr/Lukas%20ESPOIR%20ClinExpRheum%202009.pdf
Link to the document http://sfr.larhumatologie.fr/rc/rhumatologie/htm/Article/2010/59d645a5cc26d0e80d4052f3ca0a70ab/src/htm_fullText/fr/Benhamou%20J%20rheumatol%20JR%202009.pdf
Link to the document http://sfr.larhumatologie.fr/rc/rhumatologie/htm/Article/2010/59d645a5cc26d0e80d4052f3ca0a70ab/src/htm_fullText/fr/Guennoc-JRheumatol%20june%2009.pdf
Link to the document http://tinyurl.com/HAL-ESPOIR
Description List of publications in HAL
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/?term=espoir+AND+arthritis
Description List of publications in Pubmed
Access
Terms of data access (charter for data provision, format of data, availability delay) Project data following call for proposals (twice per year) addressed to the Chairman of the Scientific Council and reviewed by two specialists. Final approval is given by the Scientific Council. Specific data are transferred after signing an agreement. A list of publications and works is available on the website.
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here